In conclusion, this study identified candidate biomarkers—RPL14, SMARCD3, and TCN1—linked to immune cell activity and metabolic reprogramming in ARDS, and developed an ANN model. The gene discussed is SMARCD3; the disease is acute respiratory distress syndrome.